Navigation Links
Biodel Reports First Quarter Fiscal Year 2011 Financial Results
Date:2/3/2011

company's new drug application for Linjeta™; the company's response to the complete response letter; the importance of the complete response letter; and the company's focus, goals, strategy, research and development programs, and ability to develop and commercialize product candidates.  Forward-looking statements represent our management's judgment regarding future events.  All statements, other than statements of historical facts, including statements regarding our strategy, future operations, future clinical trial results, future financial position, future revenues, projected costs, prospects, plans and objectives of management are forward-looking statements.  The words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.  The company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to respond to the complete response letter regarding our new drug application for Linjeta™ in a timely manner and the possibility that information we provide in response to the letter may not be accepted by the FDA; our ability to secure FDA approval for Linjeta™ and our other product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel™ technology; the progress or success of our research, development and clinical programs and the initiation and completion of our clinical trials; the possibility that patients taking Li
'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
2. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
3. Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer
4. Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results
5. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
6. Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting
7. Biodel Awarded $1.2 Million in Therapeutic Discovery Research Grants From IRS
8. FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjetaâ„¢
9. Biodel to Present at Upcoming Conferences
10. Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
11. Biodel Appoints Arthur Urciuoli to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Mezzion Pharma Co. Ltd., announced that ... use of udenafil to treat adolescents who have undergone ... The clinical program will follow protocols developed by a ... Network (PHN), a multi-center clinical research network funded by ... the National Institutes of Health (NIH). ...
(Date:7/23/2014)... 8,000 attendees will converge in Washington D.C. ... (RBC), taking place July 23-26 at the Gaylord National ... to "Lead Change" in the pharmacy profession, in their ... future. "RBC is the perfect opportunity for ... learn new ways they can lead change in healthcare ...
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
Breaking Medicine Technology:Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 62014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... N.M., June 3, 2011 Rep. Ed Whitfield, R-Ky., ... that will set federal minimum education and certification standards ... planning and delivering all medical imaging examinations and radiation ... Excellence ( CARE ) in Medical Imaging and Radiation ...
... 3, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, ... Interested parties may access a live webcast of ... It is recommended that listeners log on ...
Cached Medicine Technology:Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 2Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 3Onyx Pharmaceuticals to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:7/23/2014)... the University of Exeter has developed a simple, ... frequently fatal lung disease which attacks immune deficient ... transplant recipients. , The lateral-flow device (LFD), created ... a notoriously difficult to diagnose disease caused by ... , Invasive aspergillosis is a leading cause of ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
(Date:7/23/2014)... 23, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... in a wide range of health and wellness-related fields. ... and award-winning author Nancy Kriseman, and will cover the ... prevent burnout by becoming more self-aware. In particular, Nancy ...
(Date:7/23/2014)... in Shaanxi province, and the University of California, Davis, ... groundwork for establishing the Sino-U.S. Joint Research Center for ... held in the city of Yingchuan, China, during a ... Agriculture and China,s Ministry of Science and Technology. , ... and for our World Food Center and serves as ...
(Date:7/23/2014)... Thousands of DePuy Pinnacle hip lawsuits ... federal multidistrict litigation underway in U.S. District Court, Northern ... an Order dated July 18th, U.S. District Judge Ed ... a $1,000 fee for the preservation and return of ... things, the Order noted that there is no evidence ...
Breaking Medicine News(10 mins):Health News:New device detects deadly lung disease 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4
... women in the United States will have an osteoporosis-related fracture ... published in the May 2010 issue of the Journal ... a few of these women will be tested and treated ... their risk of future fractures. "Less than 10 percent ...
... ... Affiliates Medical Group, a Torrance, California-based healthcare organization, today announced the acquisition of ... 67,000 managed care patients in Los Angeles County and Orange County, California. ... Torrance, ...
... friends and good communication are key, study finds , ... an important role in preventing their children from becoming ... know their friends, a new study suggests. , ... could have a substantial impact on child bullying," said ...
... A new study shows that a family of molecules ... control many important functions in healthy cells, but that ... , The research, led by scientists at the ... Hospital and Richard J. Solove Research Institute in collaboration ...
... feel that their Government has managed the financial crisis quite well. ... two of the findings presented in a new report by the ... of what may be the worst financial crisis since the 1930s, ... in a new SOM report presented Tuesday at a seminar at ...
... Best practices for managing medical emergencies in dental clinics ... advances in knowledge and the development of new medications ... School of Dental Medicine and an expert on dental ... an updated list of emergency medications and equipment for ...
Cached Medicine News:Health News:Women want answers, but what questions should be asked? 2Health News:Women want answers, but what questions should be asked? 3Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 2Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 3Health News:Involved Parents Less Likely to Raise Bullies 2Health News:Cancer cells show rewired, fragmented microRNA networks 2Health News:Swedes think highly of the government -- but not of the royal family 2Health News:New emergency preparedness information available for dental offices 2
... ACONO H. pylori Rapid Test Strip and ... qualitative detection of antibodies to Helicobacter pylori ... plasma to aid in the diagnosis of ... of age and older. They are intended ...
... is a lateral-flow immuno-chromatographic assay intended for ... specific to Helicobacter pylori in human serum, ... convenient, non-invasive, and easy to perform test ... of H.pylori infection in patients with clinical ...
... The Trinity Biotech Uni-Gold™ H. ... rapid, in vitro qualitative detection of ... pylori) in adult human serum, plasma ... in the diagnosis of H. pylori ...
... FDA approved rapid point-of-care fingerstick ... used to aid in the ... CLIA waived test, which detects ... HIV-1, requires only a drop ...
Medicine Products: